T. Rowe Price Associates’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,300
| Closed | -$50K | – | 3093 |
|
|
2024
Q3 | $50K | Hold |
13,300
| – | – | ﹤0.01% | 2928 |
|
|
2024
Q2 | $75K | Sell |
13,300
-2,448
| -16% | -$13.8K | ﹤0.01% | 2792 |
|
|
2024
Q1 | $83K | Buy |
+15,748
| New | +$83K | ﹤0.01% | 2810 |
|
|
2023
Q1 | – | Sell |
-15,893
| Closed | -$465K | – | 2960 |
|
|
2022
Q4 | $465K | Buy |
15,893
+1,018
| +7% | +$29.8K | ﹤0.01% | 2158 |
|
|
2022
Q3 | $393K | Buy |
14,875
+5,231
| +54% | +$138K | ﹤0.01% | 2247 |
|
|
2022
Q2 | $428K | Sell |
9,644
-3,444
| -26% | -$153K | ﹤0.01% | 2277 |
|
|
2022
Q1 | $648K | Sell |
13,088
-179
| -1% | -$8.86K | ﹤0.01% | 2217 |
|
|
2021
Q4 | $676K | Sell |
13,267
-208
| -2% | -$10.6K | ﹤0.01% | 2241 |
|
|
2021
Q3 | $752K | Sell |
13,475
-10
| -0.1% | -$558 | ﹤0.01% | 2184 |
|
|
2021
Q2 | $577K | Sell |
13,485
-1,554
| -10% | -$66.5K | ﹤0.01% | 2317 |
|
|
2021
Q1 | $628K | Sell |
15,039
-4,801
| -24% | -$200K | ﹤0.01% | 2251 |
|
|
2020
Q4 | $924K | Sell |
19,840
-6,103
| -24% | -$284K | ﹤0.01% | 1981 |
|
|
2020
Q3 | $1.1M | Buy |
25,943
+7,156
| +38% | +$304K | ﹤0.01% | 1751 |
|
|
2020
Q2 | $901K | Sell |
18,787
-1,449
| -7% | -$69.5K | ﹤0.01% | 1836 |
|
|
2020
Q1 | $931K | Buy |
20,236
+4,464
| +28% | +$205K | ﹤0.01% | 1731 |
|
|
2019
Q4 | $948K | Buy |
15,772
+500
| +3% | +$30.1K | ﹤0.01% | 1903 |
|
|
2019
Q3 | $864K | Buy |
15,272
+250
| +2% | +$14.1K | ﹤0.01% | 1877 |
|
|
2019
Q2 | $836K | Buy |
15,022
+20
| +0.1% | +$1.11K | ﹤0.01% | 1906 |
|
|
2019
Q1 | $757K | Buy |
15,002
+54
| +0.4% | +$2.73K | ﹤0.01% | 1961 |
|
|
2018
Q4 | $602K | Buy |
14,948
+1,818
| +14% | +$73.2K | ﹤0.01% | 2003 |
|
|
2018
Q3 | $910K | Buy |
13,130
+4,121
| +46% | +$286K | ﹤0.01% | 1905 |
|
|
2018
Q2 | $682K | Buy |
9,009
+37
| +0.4% | +$2.8K | ﹤0.01% | 2005 |
|
|
2018
Q1 | $473K | Buy |
8,972
+68
| +0.8% | +$3.59K | ﹤0.01% | 2103 |
|
|
2017
Q4 | $476K | Sell |
8,904
-23,234
| -72% | -$1.24M | ﹤0.01% | 2094 |
|
|
2017
Q3 | $1.92M | Sell |
32,138
-19,227
| -37% | -$1.15M | ﹤0.01% | 1572 |
|
|
2017
Q2 | $4.05M | Buy |
51,365
+45,196
| +733% | +$3.57M | ﹤0.01% | 1438 |
|
|
2017
Q1 | $512K | Sell |
6,169
-5,000
| -45% | -$415K | ﹤0.01% | 2061 |
|
|
2016
Q4 | $886K | Buy |
11,169
+1,764
| +19% | +$140K | ﹤0.01% | 1823 |
|
|
2016
Q3 | $658K | Buy |
+9,405
| New | +$658K | ﹤0.01% | 1905 |
|